CBD

FDA Approves Epidiolex for New Condition That Causes Benign Tumors, Seizures

Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.

Congress

House Passes Spending Bill with Cannabis Protections

The protections range from expanding banking access to preventing federal interference in states with legal cannabis, but passage in the Senate is uncertain.

Colorado

Colorado: New State Work Group Holds First Meeting on Cannabis Equity

Two meetings this summer will focus on recently-passed legislation that aims to expand equity in the cannabis industry.

Caribbean

Saint Lucia Joins the Race to Legalize Cannabis

The nation’s leaders have agreed to draw up adult-use legislation and set a date to vote on it.

CBD

Hemp Groups to Meet with White House on FDA CBD Policy

The Food and Drug Administration drafted its long-awaited CBD policy, and sent it to the White House Office of Management and Budget for approval, a final step before publication.

Newsletter

Democrats’ 2020 platform excludes cannabis legalization • FDA wraps CBD policy draft • & more…

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

Lobbying

Canopy Growth’s US Lobbying Footprint Expands

One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.

Lobbying, Texas

Today, Texas’ Cannabis Industry Is Tiny. Cannabis Giants See Potential.

Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.

Lobbying

Who Is Now Lobbying on Cannabis, CBD, and Hemp?

Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.